Extended Paxlovid treatment fails to ease long COVID symptoms in 959-person trial
A clinical trial published in Lancet Infectious Diseases found that Paxlovid, an antiviral drug commonly used to treat acute COVID-19, does not alleviate long COVID symptoms when treatment is extended. The study involved 959 participants.
